First AI-designed universal vaccine enters human trials

A vaccine whose active ingredient was entirely designed by artificial intelligence has been tested in humans for the first time, according to a study released Friday by the University of Cambridge. The experimental jab, intended as a 'universal vaccine,' targets a broad range of viruses including those behind Sars, Mers, and Covid-19. In a small early trial, the vaccine showed a 'modest' effect on immune systems. Researchers hope this approach could make vaccine development proactive rather than reactive, potentially helping to fend off future pandemics. Co-author Jonathan Heeney stated, 'We've converted vaccine development from being reactive to being future proof.' Currently, vaccines for flu and Covid require regular updates to match new strains.